Cargando…

Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy

BACKGROUND/OBJECTIVE: To explore acceptability by patients and health care professionals of a new surveillance pathway for people with previously treated and stable diabetic macular oedema (DMO) and/or proliferative diabetic retinopathy (PDR). SUBJECT/METHODS: Structured discussions in 10 focus grou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prior, Lindsay, Lois, Noemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102164/ https://www.ncbi.nlm.nih.gov/pubmed/35523861 http://dx.doi.org/10.1038/s41433-022-02050-1

Ejemplares similares

Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study
por: Maredza, Mandy, et al.
Publicado: (2022)

Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema
por: Foos, William F, et al.
Publicado: (2022)

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
por: Perais, Jennifer, et al.
Publicado: (2023)

Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial
por: Jukić, Anđela, et al.
Publicado: (2022)

Current treatments in diabetic macular oedema: systematic review and meta-analysis
por: Ford, John Alexander, et al.
Publicado: (2013)

Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
por: Lois, Noemi, et al.
Publicado: (2019)

Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
por: Amoaku, Winfried M., et al.
Publicado: (2020)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Full-thickness macular hole formation in proliferative diabetic retinopathy
por: Tsui, Mei-Chi, et al.
Publicado: (2021)

Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
por: Romero-Aroca, Pedro, et al.
Publicado: (2016)

Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)

Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
por: Poku, Edith, et al.
Publicado: (2013)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020)

Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes
por: Graue-Hernandez, Enrique O, et al.
Publicado: (2020)

Association of vitreous vitamin C depletion with diabetic macular ischemia in proliferative diabetic retinopathy
por: Park, Sung Wook, et al.
Publicado: (2019)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study
por: Lobo, Conceição, et al.
Publicado: (2022)

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Proportion of people with diabetic retinopathy and macular oedema varies by ethnicity in a tertiary retinal clinic in Australia: findings from the Liverpool Eye and Diabetes Study (LEADS)
por: Liew, Gerald, et al.
Publicado: (2023)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
por: Aljundi, Wissam, et al.
Publicado: (2022)

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
por: Arabi, Amir, et al.
Publicado: (2022)

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
por: Xie, Xiao, et al.
Publicado: (2023)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
por: Andrés-Blasco, Irene, et al.
Publicado: (2023)

Macular vessel density before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy
por: Abdelhalim, Ahmed Shawkat, et al.
Publicado: (2022)

Novel optical coherence tomography angiography biomarkers in the diagnosis and assessment of diabetic macular edema and diabetic macular ischemia in patients with non-proliferative diabetic retinopathy
por: Thaker, Shivna, et al.
Publicado: (2023)

Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial
por: Mistry, Hema, et al.
Publicado: (2023)

Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
por: Guan, Jian, et al.
Publicado: (2020)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
por: Do, Diana V., et al.
Publicado: (2022)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
por: ROA Vandekerckhove, Kristof
Publicado: (2015)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
por: Mateos-Olivares, Milagros, et al.
Publicado: (2021)

Growth Factors in Proliferative Diabetic Retinopathy
por: Khan, Zia Ali, et al.
Publicado: (2003)

Candidate Genes for Proliferative Diabetic Retinopathy
por: Petrovič, Daniel
Publicado: (2013)

Predicting Development of Proliferative Diabetic Retinopathy
por: Harris Nwanyanwu, Kristen, et al.
Publicado: (2013)

The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy
por: Zhu, Xuemei, et al.
Publicado: (2015)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f0boltbp7svhlhbg8j8v6fa1l5